New research reveals the HPV vaccine significantly reduces the risk of multiple HPV-related cancers, particularly head and neck cancers in men, highlighting its crucial role in cancer prevention.
Conexiant
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
Eli Lilly's JAK inhibitor demonstrated 80% scalp hair regrowth in 42.4% of adolescents with severe alopecia areata after just 36 weeks of treatment, outperforming placebo in the Phase 3 BRAVE-AA-PEDS trial.
Discover how exposure to certain fruits, vegetables, drugs, and plants can trigger symptoms of photocontact dermatitis and the importance of seeking shade and wearing protective clothing in the sun.
New clinical trials presented at the American Diabetes Association's Scientific Sessions show that survodutide has promising results for reducing HbA1c levels and improving insulin sensitivity, with additional favorable changes in glucose-related biomarkers.
Cutting-edge triple-drug therapies for leukemia discussed at the American Society of Hematology meeting show promising results in achieving remission and managing residual disease.